LCM
IBB icon

Logan Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Logan Capital Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$1.45K – 354
2025
Q3 		$1.45K Hold
10
– – ﹤0.01% 408
2025
Q2 		$1.27K Hold
10
– – ﹤0.01% 408
2025
Q1 		$1.29K Hold
10
– – ﹤0.01% 498
2024
Q4 		$1.33K Hold
10
– – ﹤0.01% 472
2024
Q3 		$1.46K Hold
10
– – ﹤0.01% 450
2024
Q2 		$1.38K Hold
10
– – ﹤0.01% 438
2024
Q1 		$1.38K Hold
10
– – ﹤0.01% 443
2023
Q4 		$1.36K Buy
+10
New +$1.22K ﹤0.01% 468

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Logan Capital Management's IBB Position: Q4 2025 in Review

Logan Capital Management sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 10 shares — an estimated $1.45K sold.

Logan Capital Management first reported a position in IBB in Q4 2023 and held it in 8 quarters. The position peaked at $1.46K in Q3 2024. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Logan Capital Management reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Logan Capital Management sold 10 iShares Biotechnology ETF shares in Q4 2025, an estimated $1.45K.
  • Logan Capital Management first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 8 quarters.
  • Logan Capital Management's iShares Biotechnology ETF position peaked at $1.46K in Q3 2024.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Logan Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.